In addition to its regulation by p38β MAPK through its phosphorylation on Thr-188 as discussed earlier, the most recent evidence [104] indicates that C/EBPβ activation in response to tumor requires a site-specific acetylation of its Lys-39 residue mediated by p300. The gene discussed is CEBPB; the disease is neoplasm.